Addition of an immunomodulator can reverse antibody formation and loss of response in patients treated with adalimumab.
Ungar B, Kopylov U, Engel T, Yavzori M, Fudim E, Picard O, Lang A, Williet N, Paul S, Chowers Y, Bar-Gil Shitrit A, Eliakim R, Ben-Horin S, Roblin X.
Ungar B, et al. Among authors: fudim e.
Aliment Pharmacol Ther. 2017 Jan;45(2):276-282. doi: 10.1111/apt.13862. Epub 2016 Nov 16.
Aliment Pharmacol Ther. 2017.
PMID: 27862102